[Role of genetic markers in personalization of anti-angiogenic therapy in patients with exudative age-related macular degeneration]. / Rol' geneticheskikh markerov v personalizatsii antiangiogennoi terapii ékssudativnoi formy vozrastnoi makuliarnoi degeneratsii.
Vestn Oftalmol
; 133(6): 120-125, 2017.
Article
en Ru
| MEDLINE
| ID: mdl-29319678
The review presents data of clinical and pharmacogenetic research by Russian and foreign authors conducted within the last three years on the effectiveness of anti-angiogenic treatment against wet age-related macular degeneration (AMD). Scientific results on the association between angiogenesis-related gene polymorphisms responsible for predisposition to AMD on the one hand and a positive response to anti-VEGF therapy on the other are presented. Particular attention is paid to the main regulator of angiogenesis - the VEGF-A gene.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de la Angiogénesis
/
Factor A de Crecimiento Endotelial Vascular
/
Degeneración Macular
Tipo de estudio:
Diagnostic_studies
Límite:
Aged
/
Humans
Idioma:
Ru
Revista:
Vestn Oftalmol
Año:
2017
Tipo del documento:
Article
Pais de publicación:
Rusia